As the FOXP1 transcription factor and its regulatory networks are highly conserved,[73] it is likely that reduced PDE10A expression is a major contributor to the symptomatology not only in mice but also in humans with FOXP1 syndrome. The gene discussed is FOXP1; the disease is Down syndrome.